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This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).SUMMARYSelf-renewal and differentiation of neural stem cells is essential for embryonic neurogenesis, which is associated with cell autophagy.
However, the mechanism by which autophagy regulates neurogenesis remains undefined. Here, we show that Eva1a/Tmem166, an auto-
phagy-related gene, regulates neural stem cell self-renewal and differentiation. Eva1a depletion impaired the generation of newborn neu-
rons, both in vivo and in vitro. Conversely, overexpression of EVA1A enhanced newborn neuron generation andmaturation. Moreover,
Eva1a depletion activated the PIK3CA-AKT axis, leading to the activation of the mammalian target of rapamycin and the subsequent
inhibition of autophagy. Furthermore, addition of methylpyruvate to the culture during neural stem cell differentiation rescued the
defective embryonic neurogenesis induced by Eva1a depletion, suggesting that energy availability is a significant factor in embryonic
neurogenesis. Collectively, these data demonstrated that EVA1A regulates embryonic neurogenesis bymodulating autophagy. Our results
have potential implications for understanding the pathogenesis of neurodevelopmental disorders caused by autophagy dysregulation.INTRODUCTION
Neural stem cells (NSCs) are a class of multipotent cells
responsible for generating all types ofneural cells in thener-
vous system and for maintaining the stem cell population
by self-renewal (Gage, 2000). The transition of proliferative
and multipotent NSCs to fully differentiated neurons is
called neurogenesis. Neurons are generated mainly from
early embryonic development to early postnatal stages. Af-
ter this phase, only a fewneurogenic zones remain active in
the adult brain (Gotz and Huttner, 2005; Ming and Song,
2011; Paridaen and Huttner, 2014). Embryonic neurogene-
sis is essential for themaintenanceofNSCs, aswell as for the
generation of functional neural cell types and is therefore
important for brain development and function.
Autophagy is an evolutionarily conserved process in
which cellular proteins and organelles are engulfed by au-
tophagosomes and delivered to lysosomes for degradation.
Autophagy is involved in a wide variety of physiological
and pathological processes, such as cancer, immune and in-
fectious diseases, and neurodegeneration (Jaeger andWyss-
Coray, 2009; Rosello et al., 2012). Among these diseases,
the role of autophagy in neurodegeneration has been stud-
ied extensively. Deletion of autophagy-related genes, such
as Atg5 and Atg7, caused dysregulation of autophagosome
formation and consequent neurodegeneration (Komatsu
et al., 2005, 2006; Kuma et al., 2004). In fact, many studies
have suggested that modulators of autophagy may be used
as potential therapeutic strategies to treat diseases caused
by autophagy defects (Harris and Rubinsztein, 2012; Nassif396 Stem Cell Reports j Vol. 6 j 396–410 j March 8, 2016 j ª2016 The Authoand Hetz, 2011; Dalby et al., 2010). Although studies have
suggested that autophagy has neuroprotective effects, the
role of autophagy in regulating embryonic neurogenesis re-
mains largely unknown.
Previous studies have demonstrated that autophagy
occurs in physiological conditions in the brain during the
development of the nervous system and that it plays a sig-
nificant role in cell differentiation (Schweichel andMerker,
1973; Zhao et al., 2010; Zeng and Zhou, 2008). Some auto-
phagy-related genes that function in the inhibition of neu-
rodegeneration are also essential for CNS development.
Specifically, AMBRA1, an activating molecule in BECLIN
1-regulated autophagy, is essential for the development of
the nervous system (Fimia et al., 2007; Yazdankhah et al.,
2014; Vazquez et al., 2012). Another autophagy-related
gene, Atg5, plays an important role in neurogenesis and
gliogenesis. (Vazquez et al., 2012; Lv et al., 2014; Wang
et al., 2014). These findings suggested a critical role of auto-
phagy in the development of the nervous system.However,
the precise mechanisms through which neurogenesis is
regulated by autophagy is far from being well elucidated.
Manymolecular targets of this process need to be identified.
EVA1A (Eva-1 homolog A), also known as TMEM166
(Transmembrane protein 166) or FAM176A (Family with
sequence similarity 176), is a lysosome and ER-associated
protein that can regulate cell autophagy and apoptosis
(Wang et al., 2007). It is conserved in humans, chimpan-
zees, rats, mice, and dogs, indicating that it may have
important functions in vertebrate animals. Previous studies
revealed that EVA1A is expressed in a cell-type-specific andrs
tissue-type-specific manner and is significantly downregu-
lated in cancer tissues (Xu et al., 2013; Sun et al., 2012; Tao
et al., 2015). In vivo and in vitro experiments demon-
strated that EVA1A overexpression inhibits tumor cell pro-
liferation by autophagy (Chang et al., 2013; Xie et al.,
2014). These findings suggested a close correlation between
EVA1A-induced autophagy and cancer suppression. Other
studies have suggested that EVA1A-induced autophagy
plays a significant role in cell death following focal cerebral
ischemic injury (Li et al., 2012). Lu et al. (2015) demon-
strated that EVA1A/TMEM166 is a key player in C/EBPa-
mediated autophagy induction and protection against star-
vation. However, the role of EVA1A in neurogenesis has not
been reported, and the mechanism by which EVA1A regu-
lates autophagy remains to be determined.
In the present study, we generated an Eva1a knockout
(KO) mouse to study the physiological role of EVA1A
in vivo. The analysis of Eva1a KO embryos and isolated
NSCs revealed the function of EVA1A in self-renewal and
neuronal differentiation of NSCs. Our study highlighted a
previously unknown role of EVA1A in the CNS.RESULTS
EVA1A Expression in Brain Development
To determine the role of EVA1A in brain development, we
first evaluated the expression of EVA1A in the embryonic
cortex from embryonic day 10.5 (E10.5) to E16.5 and post-
natal 2 day (P2). Western blotting revealed that EVA1A
expression increased substantially from E10.5 to E16.5
and gradually decreased after P2 (Figures S1A and S1B).
Consistent with this observation, immunofluorescence
and confocal microscopy observations indicated that the
fluorescence signals of EVA1A were elevated at E10.5 and
peaked at E16.5 (Figure S1C). Interestingly, the level of
autophagy, which is indicated by the autophagy marker
LC3B-II, also increased from E10.5 to E16.5 (Figures S1A,
S1B, and S1D). Simultaneously, b-TUBULIN III, the neuron
marker, was markedly upregulated during this period (Fig-
ures S1A, S1B, and S1E). These results demonstrate that
neuron differentiation occurs at the early embryonic devel-
opment stage and the initiation of neuron differentiation
corresponds to the expression of EVA1A and the autophagy
level, suggesting that EVA1A might be involved in brain
development including neuron differentiation.Generation of Eva1a Gene Knockout Mice
To investigate the physiological function of EVA1A in the
development of the CNS, we generated Eva1a gene KO
mice. To this end, we crossed Eva1aflox/flox mice (Figure 1A)
with transgenic mice expressing Cre recombinase under
the control of the Nestin promoter (Nestin-Cre). TheStemEva1a+/+ and Eva1a/ mice were identified by PCR anal-
ysis of mouse tail DNA (Figure 1B). The results of RT-PCR
and western blotting demonstrated that the level of
EVA1A was low or absent in the indicated brain areas (cor-
tex, hippocampus, and cerebellum) in Eva1a/ mice at
E12.5 (Figures 1C and 1D). Consistent with this result,
an immunofluorescence assay confirmed that EVA1A pro-
tein signals were nearly absent in the cortex of the
Eva1a/ mice (Figure 1E versus 1F). We also evaluated
the protein level of EVA1A in other tissues, such as liver,
lung, heart, and muscle. There was no significant change
between the Eva1a/ and Eva1a+/+ mice (data not
shown), indicating that the EVA1A deficiency was
restricted to the CNS.
Eva1a Deletion Decreases the Ability of NSCs Self-
Renewal, but Fails to Induce Cell Apoptosis
To investigate the role of EVA1A in NSC self-renewal, we
first detected the expression of the NSCs markers, NESTIN
and SOX2, in the whole-brain tissue at E12.5 in both
Eva1a/ and Eva1a+/+ mice. Our results revealed that the
levels of both NESTIN and SOX2 were markedly decreased
in the Eva1a/ mice (Figure 2A). We next injected bromo-
deoxyuridine (BrdU) into both the Eva1a+/+ and Eva1a/
mice at E12.5 and detected proliferating cells in living tis-
sues. After 4 hr, the frozen sections were obtained from
whole-brain samples and subjected to immunofluores-
cence assay. Confocal microscopy showed that the
Eva1a/ mice displayed a weaker signal for NESTIN stain-
ing (Figure 2B versus 2C, left panel) and the number of NES-
TIN+ BrdU+ positive cells was decreased in the Eva1a/ cor-
tex compared with those in the Eva1a+/+ mice, indicating
the number of newborn NSCs was reduced in the Eva1a/
mice (Figures 2B–2D). To rule out the possibility that the
reduction in NSCs was the result of cell apoptosis, we per-
formed a terminal deoxynucleotidyl transferase dUTP
nick end labeling (TUNEL) assay in brain sections. There
was no significant difference in TUNEL-positive cells be-
tween Eva1a/ and Eva1a+/+ mice, indicating that the
decrease in NSC self-renewal is independent of apoptosis
(Figures 2E–2G).
Wenext investigated the influence of EVA1AonNSC self-
renewal in vitro. As shown in Figures 2H and 2I, the num-
ber of secondary neurospheres generated from Eva1a/
NSCs was markedly lower than that from Eva1a+/+ NSCs.
At the same time, deletion of Eva1a in NSCs resulted in
smaller-sized neurospheres compared with their Eva1a+/+
counterparts (Figures 2H and 2J), indicating defective self-
renewal in Eva1a/ NSCs. Furthermore, Annexin V stain-
ing and flow cytometry analysis indicated there was no sig-
nificant difference in cell apoptosis between Eva1a/
NSCs and Eva1a+/+ NSCs (Figures 2K and 2L), excluding
the possibility that the defective NSC self-renewal wasCell Reports j Vol. 6 j 396–410 j March 8, 2016 j ª2016 The Authors 397
Figure 1. Generation of Eva1a KO Mice
(A) Scheme to generate Eva1a conditional knockout mice.
(B) Genomic DNA was extracted from mouse tails and analyzed by PCR.
(C) Brain homogenates (cortex, hippocampus, and cerebellum) were obtained from Eva1a+/+ mice and Eva1a/ mice at E12.5. The Eva1a
mRNA level was analyzed by RT-PCR, and the protein level was analyzed by western blotting.
(D) Statistical analysis of the level of Eva1a in different regions of the brain. The average value in Eva1a+/+ brain tissues was normalized as
1. Data are means ± SD of the results from three independent experiments. ***p < 0.001; t test.
(E and F) Frozen sections were obtained from whole-brain samples of both Eva1a+/+ and Eva1a/ mice at E12.5, and an immunofluo-
rescence assay was carried out to detect EVA1A expression in the cortex (scale bar, 100 mm). The right panel shows higher magnifications
(scale bar, 10 mm). The white arrow indicates the EVA1A protein signal in the whole-brain samples.
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Figure 2. Eva1a Knockout Decreases NSCs Self-Renewal, but Fails to Induce Cell Apoptosis
(A) Immunoblot analysis of EVA1A, NESTIN, and SOX2 expressions in whole-brain tissue from Eva1a+/+ and Eva1a/ mice at E12.5.
(B and C) Pregnant female mice at E12.5 were injected intraperitoneally with BrdU 4 hr before euthanasia. Brain frozen sections were
obtained and subjected to an immunofluorescence assay. Representative confocal microscopy images of the fluorescence of NESTIN and
BrdU were analyzed. Scale bar, 100 mm.
(D) Quantification of BrdU and NESTIN double-positive cells within a 350-mm slab of the brain section in Eva1a+/+ and Eva1a/ littermate
mice. Five randomly selected sections from each mouse were examined. Three independent experiments were performed. Data are means ±
SD **p < 0.01; t test.
(legend continued on next page)
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caused by apoptosis. Collectively, these observations sup-
ported a positive role of EVA1A in NSC self-renewal.
NSCs Differentiation Is Impaired in Eva1a/ Mice
Having demonstrated the correlation between EVA1A and
NSC self-renewal, we then investigated the effect of
EVA1A onNSCdifferentiation.We first examined the levels
of both EVA1A and b-TUBULIN III (a marker of neurons) in
Eva1a/ and Eva1a+/+ mice at E16.5. As shown in Figures
3A–3D, Eva1a was nearly absent in Eva1a/, which is asso-
ciated with a concomitant decrease in b-TUBULIN III pro-
tein. Data from immunofluorescence assay in brain frozen
sections confirmed that the b-TUBULIN III showed a stron-
ger fluorescence signal in Eva1a+/+ mice than in Eva1a/
mice (Figure 3E versus 3F, left panel). Meanwhile, the num-
ber of b-TUBULIN III+ BrdU+ double-positive cells within a
350-mm slab of the brain was significantly downregulated
in Eva1a/mice (from around 31.66% to 14.33%) (Figures
3E–3G), suggesting damage to the newborn neuron
population.
Next, we established NSC cultures, in which the transi-
tion from proliferative to differentiated cells can be easily
monitored in short-term cell culture, following treatment
with all-trans retinoic acid for direct neuronal differentia-
tion. NSCs from Eva1a+/+ and Eva1a/ mice at E12.5
were cultured under differentiation conditions for 6 days.
The levels of b-TUBULIN III were lower in Eva1a/ NSC
cultures (Figures 3H and 3I). Consistent with the results
of western blotting, the percentage of b-TUBULIN III+
differentiated neurons was decreased in Eva1a/ NSC cul-
tures (Figures 3J and 3K).We also found that the neurites of
Eva1a/ neurons were shorter than those from Eva1a+/+
neurons (Figures 3J and 3L), indicating a deficiency in neu-
rite formation and neuron maturation. Collectively, these
data suggested that EVA1A may be important for the
neuronal differentiation of NSCs.
EVA1A Modulates Autophagy through the PIK3CA/
AKT-mTOR Pathway
Previous studies have demonstrated that dysregulation of
autophagy can lead to abnormal neuronal hyperprolifera-(E and F) Frozen sections were obtained from whole-brain samples of b
assay. Representative confocal microscopy images of the fluorescenc
(G) The percentage of TUNEL-positive cells was calculated as the mea
sections from each mouse were examined. Three independent experim
(H) Eva1a+/+ and Eva1a/ NSCs were grown from E12.5 embryos unde
phase contrast microscopy and representative microscopy images are
(I and J) Eva1a+/+ and Eva1a/ NSCs were cultured in 96-well non-c
ditions as in (H). The relative neurosphere number and diameter wer
Eva1a+/+ group was normalized as 100%. Data are means ± SD of the
(K) Eva1a+/+ and Eva1a/ NSCs were grown from E12.5 embryos under
Annexin V plus propidium iodide staining kit by flow cytometry.
(L) Apoptotic cells were calculated and each bar represents the mean
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2008; Cecconi et al., 2007). We observed that autophagy
is activated during embryonic neurogenesis, which is
accompanied by an increase in EVA1A levels (Figure S1).
Therefore, we hypothesized that EVA1Amight regulate em-
bryonic neurogenesis via autophagy. Initially, we analyzed
the autophagy-related genes in the cortex of both Eva1a+/+
and Eva1a/ mice at E16.5. We found that the mRNA
levels of Atg5 and Lc3b were decreased in Eva1a-depleted
cortex tissue (Figure 4A).We nextmeasured the conversion
of LC3B using western blotting. The conversion of LC3B-I
to LC3B-II occurs during autophagy, and the amount of
LC3B-II is correlated with the number of autophagosomes
(Klionsky et al., 2012). It was shown that the accumulation
of LC3B-II was reduced in the Eva1a/ cortex compared
with the Eva1a+/+ cortex (Figure 4B). Consistent with the
results of western blotting, confocal microscopy observa-
tion indicated that the number of LC3B puncta was
decreased in the Eva1a/ cortex (Figure 4C versus 4D).
It has been widely recognized that the SQSTM1 (seques-
tosome 1)/P62 protein serves as a link between LC3 and
ubiquitinated substrates. It incorporates into the
completed autophagosome and is degraded in lysosome.
Therefore, the level of SQSTM1 is a marker for autophagic
flux (Klionsky et al., 2012). As shown in Figure 4B, the basal
level of SQSTM1 was upregulated and formed numerous
aggregates in the Eva1a/ cortex compared with the
Eva1a+/+ cortex (Figure 4E versus 4F). The presence of
strong ubiquitin stainingwas also observed in the Eva1a/
cortex (Figure 4G versus 4H), indicating blockage of auto-
phagic flux.
In vitro experiments were next performed to corroborate
the above-mentioned autophagic phenotypes. NSCs were
generated from both Eva1a/ and Eva1a+/+ mice at
E12.5. RT-PCR showed that loss of Eva1a in NSCs resulted
in a reduction of Atg5 and Lc3b mRNA levels (Figure 5A).
Simultaneously, decreased LC3B-II and increased SQSTM1
protein levels were also observed in Eva1a/ NSCs
compared with Eva1a+/+ NSCs (Figure 5B). Consistent
with the results of western blotting, the number of LC3B
dots per cell in Eva1a/ NSCs was significantly decreasedoth Eva1a+/+ and Eva1a/mice at E12.5, and subjected to a TUNEL
e were analyzed. Scale bar, 100 mm.
n of ten different fields from each section. Five randomly selected
ents were performed. Data are means ± SD. n.s., not significant.
r proliferative conditions. Neurosphere formation was viewed under
shown. Scale bar, 25 mm.
oated plates with 500 or 1,000 cells per well under the same con-
e calculated as shown in the histograms. The average value in the
results from three independent experiments. ***p < 0.001; t test.
proliferative conditions. Cell apoptosis was detected using the FITC-
± SD from three independent experiments. n.s., not significant.
rs
Figure 3. NSC Differentiation Is Impaired in Eva1a KO Mice
(A) RT-PCR analysis of Eva1a and b-tubulin III mRNA in whole-brain tissue from Eva1a+/+ and Eva1a/ mice at E16.5.
(B) Quantifications of the ratio of b-tubulin III/Gapdh. The average value in the Eva1a+/+ group was normalized as 1. Data are means ± SD
of the results from three independent experiments. ***p < 0.001; t test.
(C) Immunoblot analysis of EVA1A and b-TUBULIN III expression in whole-brain tissue from Eva1a+/+ and Eva1a/ mice at E16.5.
(D) Histogram shows the ratio of b-TUBULIN III/ACTB. The average value in the Eva1a+/+ group was normalized as 1. Data are means ± SD
of the results from three independent experiments. *p < 0.05; t test.
(E and F) Pregnant female mice at E16.5 were injected intraperitoneally with BrdU 4 hr before euthanasia. Brain frozen sections were
obtained and subjected to an immunofluorescence assay. Representative confocal microscopy images of the fluorescence of b-TUBULIN III
and BrdU were analyzed. Scale bar, 50 mm.
(G) Quantification of b-TUBULIN III and BrdU double-positive cells within a 350-mm slab of the brain section in Eva1a+/+ and Eva1a/
littermate mice. Five randomly selected sections from each mouse were examined. Three independent experiments were performed. Data
are means ± SD ***p < 0.001; t test.
(H) NSCs from Eva1a+/+ and Eva1a/mice at E12.5 were cultured under differentiation conditions for 6 days. The levels of b-TUBULIN III
were evaluated by western blotting.
(legend continued on next page)
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compared with that in Eva1a+/+ NSCs (Figures 5C and 5D).
These data were consistent with those from the mouse cor-
tex. Taken together, our data suggested that autophagic ac-
tivity was impaired in Eva1a/ cells. Importantly, the
decrease of b-TUBULIN III levels in the Eva1a/ cortex
was associated with decreased LC3B puncta, as well as
increased SQSTM1 accumulation (Figures 4C–4F), indi-
cating that Eva1a depletion-triggered damage to neurogen-
esis might result from disrupted autophagy.
We then investigated the mechanisms of the autophagy
defective in Eva1a/ cells. The mammalian target of rapa-
mycin (mTOR) has been known as a negative regulator of
autophagy. Experiments showed that the phosphoryla-
tion levels of mTOR at Ser2448 (activation site) and
RPS6KB1 (ribosomal protein S6 kinases, 70 kDa, polypep-
tide 1, a substrate of mTOR) as well as EIF4EBP1 (Eukary-
otic translation initiation factor 4E binding protein 1),
two downstream effectors of mTOR, were elevated in
the Eva1a/ cortex (Figures 4I and 4J). Furthermore, we
examined mTOR signaling in NSCs from both Eva1a/
and Eva1a+/+ NSCs at E12.5. As shown in Figures 5E and
5F, the levels of p-mTOR, p-RPS6KB1, and p-EIF4EBP1
were elevated in the Eva1a/ NSCs. Collectively, these re-
sults support the hypothesis that an increase of mTOR ac-
tivity contributes functionally to the autophagy defect in
Eva1a/ cells.
The PIK3CA-AKT signaling pathway plays a key role in
various cellular processes, including cell growth, prolifera-
tion, survival, and autophagy. Activation of PIK3CA results
in phosphorylation of phosphatidylinositol 4,5-bisphos-
phate (PIP2) to form PIP3. Subsequently, PIP3 recruits
downstream effector proteins such as serine/threonine ki-
nase AKT. Once activated, AKT-mediated phosphorylation
of TSC2 (tuberous sclerosis complex 2) inhibits the TSC1-
TSC2 complex function, and thus activates mTOR
signaling. Therefore, further experiments were performed
to determine the influence of Eva1a deletion on PIK3CA-
AKT signal. As shown in Figures 4K and 4L, there was a sig-
nificant increase in the phosphorylation of PIK3CA and
AKT in the Eva1a/ cortex at E16.5. Importantly, the basal
phosphorylation levels of TSC2 were decreased. Similarly,
we analyzed the PIK3CA/AKT signaling pathway in NSCs
at E12.5. Consistent results were obtained in the absence
of Eva1a in NSCs (Figures 5G and 5H). Taken together,
these results suggested that loss of Eva1a leads to the activa-(I) Quantifications of the amount b-TUBULIN III protein relative t
normalized as 1. Data are means ± SD of the results from three indep
(J) The treatment of NSCs was the same as in (H), after which, the c
viewed under a confocal microscope. Scale bar, 75 mm.
(K and L) Five randomly selected areas from each slide were examine
b-TUBULIN III+ cells with neurites under the fluorescence microscope
SD. **p < 0.01; t test.
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tion of TSC2 and the subsequent activation of mTOR
signals.
Overexpression of EVA1A Restores Self-Renewal and
Neuronal Differentiation in Eva1a/ NSCs
Eva1a depletion induced defects in NSC differentiation;
therefore, we performed reciprocal EVA1A gain-of-function
experiments using NSCs at E12.5 and an Ad5-Eva1a
construct. The number and the size (diameter) of secondary
neurosphere formed from the NSCs were used as a measure
of NSC self-renewal. Our results showed that neurosphere
formation was decreased in Eva1a-deleted NSCs compared
with that of Eva1a+/+ NSCs. However, overexpression of
EVA1A in Eva1a/ NSCs increased the number of neuro-
spheres (Figures 6A and 6B, left panel). Meanwhile, the
neurosphere diameter in EVA1A-overexpressing Eva1a/
NSCswas greater than that of Eva1a/NSCs alone (Figures
6A and 6B, right panel). In addition, Eva1a/ NSCs al-
lowed to differentiate in cultures generated a small number
of b-TUBULIN III-positive neurons compared with that in
Eva1a+/+ NSCs (Figure 6D, left panel). After EVA1A overex-
pression in Eva1a/NSCs, the percentage of differentiated
neurons increased from around 15% to 25% (Figure 6D, left
panel). Furthermore, compared with the Eva1a/ NSCs
alone, the Eva1a/ NSCs overexpressing EVA1A appeared
to produce longer neurites (Figures 6C and 6D, right panel),
indicating enhanced neuronal differentiation and matura-
tion by EVA1A overexpression. These results suggested that
Eva1a depletion-induced deficiency in neurogenesis can be
rescued by overexpression of EVA1A, indicating the speci-
ficity of EVA1A function.
Eva1a depletion leads to the activation of the PIK3CA/
AKT-mTOR pathway; therefore, we examined whether
overexpression of EVA1A could inactivate this pathway
and increase autophagy levels. As expected, overexpression
of EVA1A in Eva1a/ NSCs enhanced the conversion of
LC3B and SQSTM1 degradation (Figures 6E and 6F, lane 3
versus lane 2), suggesting the activation of autophagy.
Simultaneously, overexpression of EVA1A in Eva1a/
NSCs significantly downregulated the levels of p-RPS6KB1
and p-EIF4EBP1 (Figures 6E and 6F, lane 3 versus lane 2),
indicating the inhibition of the mTOR signal. We subse-
quently detected the PIK3CA-AKT signal in such condi-
tions. As shown in Figures 6G and 6H, the phosphorylationo ACTB are shown. The average value in the Eva1a+/+ group was
endent experiments. ***p < 0.001; t test.
ells were subjected to immunostaining against b-TUBULIN III and
d for the percentage of b-TUBULIN III+-differentiated neurons and
. Three independent experiments were performed. Data are means ±
rs
Figure 4. EVA1A Modulates Autophagy through the PIK3CA/AKT-mTOR Pathway
(A) The mRNA levels of autophagy-related genes in whole-brain tissue from Eva1a+/+ and Eva1a/mice at E16.5 were detected by RT-PCR.
(B) The protein levels of SQSTM1 and LC3B in whole-brain tissue were detected by western blotting.
(C–F) Brain frozen sections were obtained from both Eva1a+/+ and Eva1a/ mice at E16.5, which were then subjected to an immuno-
fluorescence assay. Representative confocal microscopy images of the distribution of b-TUBULIN III, LC3B, and SQSTM1 were analyzed.
(G and H) Representative confocal microscopy images of the distribution of ubiquitin are shown. Scale bar, 25 mm.
(I and K) Western blot analysis with the indicated antibodies in whole-brain tissue from both Eva1a+/+ and Eva1a/ mice at E16.5.
(J and L) Densitometric analysis of the immunoblots. ACTB was assessed as a loading control. The average value in the Eva1a+/+ group was
normalized as 1. Data are means ± SD of the results from three independent experiments. *p < 0.05, **p < 0.01; t test.levels of PIK3CA and AKT were decreased and TSC2 phos-
phorylation was increased in Eva1a/NSCs overexpressed
by Eva1a. Furthermore, a PIK3CA/AKT inhibitor (perifo-
sine) was used to confirm the relationship between
EVA1A-regulated autophagy and the PIK3CA/AKT-mTOR
pathway. Data from experiments indicated that perifo-
sine-mediated inhibition of PIK3CA/AKT-mTOR at least
partly rescued autophagy deficiency in Eva1a/ NSCs atStemE16.5 (Figures S2A–S2D). Importantly, we observed that
perifosine treatment could partly reverse the defective
self-renewal and defective differentiation caused by Eva1a
knockout (Figures S2E–S2H). These data further confirmed
that EVA1A regulates autophagy via the suppression of
the PIK3CA/AKT-mTOR signaling, and that EVA1A-medi-
ated autophagy is involved in self-renewal and neuronal
differentiation.Cell Reports j Vol. 6 j 396–410 j March 8, 2016 j ª2016 The Authors 403
Figure 5. Eva1a Knockout in NSCs Increases the PIK3CA/AKT-mTOR Signal Pathway
(A) NSCs from Eva1a+/+ and Eva1a/ at E12.5 were cultured under proliferation conditions. The mRNA levels of autophagy-related genes
were detected by RT-PCR.
(B) The treatment of NSCs was the same as in (A). The levels of LC3B and SQSTM1 were analyzed by western blotting.
(C) The treatment of NSCs was the same as in (A). The cells were then plated on glass coverslips coated with poly-ornithine for 24 hr. NSCs
were subjected to immunofluorescence against LC3B and viewed under a confocal fluorescence microscopy. Scale bar, 10 mm.
(D) Histogram showing the quantification of the numbers of LC3B puncta per cell under confocal microscopy. Three independent ex-
periments were performed. Results are means ± SD of at least 100 non-overlapping cells scored. ***p < 0.01; t test.
(E and G) The treatment of NSCs was the same as in (A). NSCs were lysed and subjected to immunoblot analysis using the indicated
antibodies.
(F and H) Densitometric analysis of the immunoblots. ACTB was assessed as a loading control. The average value in the Eva1a+/+ group was
normalized as 1. Data are means ± SD of the results from three independent experiments. *p < 0.05, ***p < 0.001; t test.Eva1a Depletion Induced Impaired NSC
Differentiation Can Be Reversed by Methylpyruvate
and Rapamycin
Autophagy is a potential energy source during cellular re-
structuring, which is associated with neuronal differentia-
tion and neurite outgrowth (Hara et al., 2006; Levine and
Klionsky, 2004). A recent study has demonstrated that
autophagy inhibition with 3-methyladenine (3-MA) re-
duces ATP levels during retinal neurogenesis, and this
inhibition could be reversed by treatment with methyl-
pyruvate (MP) (Mellen et al., 2008). MP is a permeable
analog for the citric acid cycle. To clarify the correlation
among EVA1A, neurogenesis, and the availability of en-
ergy in the course of autophagy, we performed the
following test. NSCs from Eva1a+/+ and Eva1a/ mice at404 Stem Cell Reports j Vol. 6 j 396–410 j March 8, 2016 j ª2016 The AuthoE12.5 were grown as neurospheres and cultured under dif-
ferentiation conditions for 6 days. In the Eva1a/ group,
the number of b-TUBULIN III+ neurons was decreased
(Figures 7A, 7B, and 7E), and the neurite length appeared
shorter than that from the Eva1a+/+ NSC group in the
normal culture (Figures 7A, 7B, and 7F), which indicated
a decrease in neuronal differentiation. However, MP treat-
ment markedly increased the number of b-TUBULIN III+
neurons and the neurite length in the Eva1a/ group
(Figures 7C–7F), while no significant changes were
observed in the Eva1a+/+ group with or without MP treat-
ment (Figures 7A and 7C). Simultaneously, we further
detected the autophagy levels under such conditions. In
normal culture conditions, the expression of b-TUBULIN
III protein was downregulated in Eva1a/ NSCsrs
Figure 6. Overexpression of EVA1A Restores Self-Renewal and Neuronal Differentiation in Eva1a/ NSCs
(A) NSCs obtained from Eva1a+/+ and Eva1a/ at E12.5 were infected or not infected with Ad5-Eva1a and further cultured for 12 hr under
proliferative conditions. Neurosphere formation in NSCs from Eva1a+/+, Eva1a/ and Eva1a/ plus Ad5-Eva1a were viewed by phase
contrast optical microscopy. Scale bar, 25 mm.
(B) NSCs from Eva1a+/+ and Eva1a/ mice were cultured in 96-well non-coated plates with 500 or 1,000 cells per well under the same
conditions as in (A). The number and the size (diameter) of secondary neurospheres were evaluated. The average value in the Eva1a+/+
group was normalized as 100%. Data are means ± SD of the results from three independent experiments. ***p < 0.001; one-way ANOVA
with Tukey’s post hoc test.
(C) NSCs obtained from Eva1a+/+ and Eva1a/ at E12.5 were infected or not infected with Ad5-Eva1a and cultured under differentiation
conditions for 6 days. Then the cells were subjected to immunostaining against b-TUBULIN III and viewed under a fluorescence micro-
scope.
(D) Five randomly selected areas from each slide were examined for the percentage of b-TUBULIN III+-differentiated neurons in total cells
and b-TUBULIN III+ cells with neurites under the fluorescence microscope. Three independent experiments were performed. Data are
means ± SD. **p < 0.01, ***p < 0.001; one-way ANOVA with Tukey’s post hoc test.
(E and G) The treatment of NSCs was the same as in (A). NSCs were lysed and subjected to immunoblot analysis using the indicated
antibodies.
(F and H) Densitometric analysis of the immunoblots. ACTB was assessed as a loading control. The average value in the Eva1a+/+ group was
normalized as 1. Data are means ± SD of the results from three independent experiments. *p < 0.05, **p < 0.01, ***p < 0.001; one-way
ANOVA with Tukey’s post hoc test.compared with that of Eva1a+/+ NSCs (Figures 7G and 7H,
lane 3 versus lane 1). Meanwhile, decreased b-TUBULIN
III was accompanied by weakened LC3B-II accumulation
and increased SQSTM1 levels (Figures 7G and 7H, lane 3
versus lane 1), which was consistent with the above
observation. After treatment with MP, b-TUBULIN III
expression showed weak upregulation. At the same time,
accumulation of LC3B-II was significantly elevated and aStemdecrease in SQSTM1 levels was observed in Eva1a/
NSCs (Figures 7G and 7H, lane 4 versus lane 3). Data
from transmission electron microscopy analysis shown
that MP treatment increased autophagic structures in
the Eva1a/ NSCs compared with that in Eva1a/
NSCs alone (Figure S3), suggesting enhanced autophagy.
Collectively, these results implied that MP treatment re-
covers impaired autophagy in Eva1a/ NSCs.Cell Reports j Vol. 6 j 396–410 j March 8, 2016 j ª2016 The Authors 405
Figure 7. MP Treatment Rescues NSC Differentiation in Eva1a/ Mice
(A–D) NSCs from Eva1a+/+ and Eva1a/ at E12.5 were grown as neurospheres, and then plated under differentiation conditions for 6 days
with or without MP (10 mM) treatment. Cells were fixed for immunofluorescence analysis. Representative fields of Eva1a+/+ and Eva1a/
neurons were stained with b-TUBULIN III antibodies. Nuclei were stained with Hoechst 33342 (scale bar, 75 mm). The right panel shows
higher magnifications (scale bar, 25 mm).
(E and F) Five randomly selected areas from each slide were examined for the percentage of b-TUBULIN III+-differentiated neurons in total
cells and b-TUBULIN III+ cells with neurites under the fluorescence microscope. Three independent experiments were performed. Data are
means ± SD. **p < 0.01; one-way ANOVA with Tukey’s post hoc test.
(G) The treatment of NSCs was the same as in (A–D), after which the NSCs were lysed and subjected to immunoblot analysis using the
indicated antibodies.
(H) Histogram showing the quantification of the ratio of the relative proteins/ACTB. The average value in the Eva1a+/+ group (lane 1) was
normalized as 1. Data are means ± SD of the results from three independent experiments. **p < 0.01, ***p < 0.001; one-way ANOVA with
Tukey’s post hoc test.
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To further consolidate the hypothesis that defective neu-
rogenesis is caused by autophagy deficiency, we utilized the
mTOR-dependent chemical rapamycin and mTOR-inde-
pendent chemical lithium (LiCl) to induce autophagy for
the rescue assay. As shown in Figures S4A and S4B, rapamy-
cin could increase autophagy both in Eva1a+/+ and
Eva1a/ NSCs at E16.5. LiCl treatment could enhance
autophagy in Eva1a+/+ NSCs (Figures S4C and S4D, lane 2
versus lane 1), but failed in Eva1a/ NSCs (Figures S4C
and S4D, lane 4 versus lane 3), indicating that the auto-
phagy impairment caused by Eva1a deletion is associated
with the mTOR activity.
We further examined the differentiation of NSCs under
the same treatment conditions. Data obtained from west-
ern blotting indicated that rapamycin treatment could in-
crease the levels ofb-TUBULIN III inEva1a/NSCs (Figures
S4A and S4B, lane 4 versus lane 3). LiCl, however, had no ef-
fect on the level of b-TUBULIN III inEva1a/NSCs (Figures
S4C and S4D, lane 4 versus lane3). Simultaneously, we
found that rapamycin treatment, but not LiCl, enhanced
the formation and maturation of neurons in Eva1a/
NSCs (Figures S4E–S4H). Together, our data reveal that the
defective neurogenesis in Eva1a/ NSCs could be rescued
bymTOR-dependent autophagymodulators, at least partly.DISCUSSION
In the present study, the role of EVA1A/TMEM166 in the
process of neurogenesis was investigated using Eva1a KO
mice. We demonstrated that EVA1A regulates NSC self-
renewal and neuronal differentiation by modulating auto-
phagy. Genetic disruption of Eva1a caused a deficiency in
the autophagic machinery, which consequently impaired
the differentiation process, decreasing the number of
newborn neurons and impeding their maturation in cul-
ture. This effect could be rescued by overexpression of
EVA1A or treatment with MP in vitro. Our studies suggest
strongly that EVA1A modulates the process of autophagy,
which may provide energy for the transition from NSCs
to mature neurons.
Several studies have suggested that autophagy is acti-
vated during nervous system development and cell differ-
entiation (Nassif and Hetz, 2011; Schweichel and Merker,
1973; Zhao et al., 2010). Initially, we observed that the
EVA1A levels increased over the course of neurogenesis,
along with a concomitant increase in autophagy in wild-
type mice. Based on this, we speculated that increased
expression of EVA1A in NSCs may play a role in neurogen-
esis. Here, we present several lines of evidence that demon-
strate that the loss of EVA1A leads to substantial decline in
NSC self-renewal, as well as in neuronal differentiation
in vivo and in vitro. The phenotype changes observed inStemEva1a-deleted NSCs could be rescued by a gain-of-function
assay in vitro.
The mechanism by which EVA1A regulates neurogenesis
is unclear. Autophagy plays a critical role in neurogenesis
and is mainly regulated by the mTOR pathway; therefore,
we examined the effect of Eva1a depletion on the mTOR
pathway. The phosphorylation levels of mTOR, RPS6KB1,
and EIF4EBP1 were increased in NSCs derived from
Eva1a/ mice. Consistent with these findings, the levels
of p-PIK3CA and p-AKT (upstream ofmTOR) also increased
in Eva1a-depleted cells, which was accompanied by a sub-
stantial decrease in p-TSC2 levels. Thus, it can be seen
that the PIK3CA-AKT signal negatively regulates TSC1/2
and activates mTOR, and consequently, inhibits auto-
phagy. Importantly, transduction ofAd5-Eva1a in Eva1a/
NSCs attenuated this PIK3CA/AKT-mTOR signaling
pathway, and restored the autophagy level. These results
were consistent with those of a previous report, which indi-
cated that overexpression of EVA1A/TMEM166 decreased
the activity of mTOR in human tumor cells (Chang et al.,
2013). Our studies indicated that EVA1A probably regulates
neurogenesis through the PIK3CA/AKT-mTOR pathway.
However, further studies are necessary to understand how
EVA1A regulates the PIK3CA/AKT axis precisely.
Autophagy is a complex catabolic program that func-
tions in the lysosomal degradation of proteins and other
subcellular constituents and serves as an effective method
of providingmetabolic precursors. Previous studies demon-
strated that neuroepithelial cells undergo differentiation in
an energy-consuming process (Vazquez et al., 2012; Mellen
et al., 2008; Qu et al., 2007), and autophagy can provide
sufficient energy for the process of neurogenesis. Until
recently, only a few studies had demonstrated the effects
of autophagy on neurogenesis in vivo. However, how auto-
phagy regulates neurogenesis remains largely unknown. In
this study, we observed that NSC self-renewal and differen-
tiation were decreased in Eva1a-deficient mice and auto-
phagy was decreased. Decreased levels of autophagy may
lead to a shortage of energy supply and impede the process
of neurogenesis; therefore, we treated Eva1a-defective
NSCs with MP. Generally, MP treatment restored neuronal
differentiation in these cells. Thus, Eva1a deletion-induced
defective neuronal differentiation is probably associated
with a lack of available energy caused by the inhibition of
autophagy.
In summary, our results revealed that loss of Eva1a leads
to impaired NSC self-renewal and differentiation, along
with a decrease in autophagy, which is inversely associated
with the activation of the PIK3CA/AKT-mTOR signaling.
Functionally, EVA1A overexpression or MP treatment
substantially rescued Eva1a-depletion-induced NSC self-
renewal and neuronal differentiation deficiency, demon-
strating the crucial function of EVA1A in embryonicCell Reports j Vol. 6 j 396–410 j March 8, 2016 j ª2016 The Authors 407
neurogenesis. Our investigations provide insights into the
activities of EVA1A, as well as the role of basal autophagy in
neurogenesis. Moreover, our results provide a basis for the
identification ofmolecular targets for the treatment of neu-
rodevelopmental disorders caused by dysregulation of
autophagy.EXPERIMENTAL PROCEDURES
Generation of Tissue-Specific Eva1a-Deficient Mice
Eva1aflox/flox mice with the C57BL/6J background were con-
structed by the Model Animal Research Center of Nanjing Univer-
sity (Nanjing, China). Nestin-Cre transgenic mice were provided
by Prof. Hong Zhang (Chinese Academy of Sciences, Beijing,
China). Progeny containing the Eva1a flox allele were bred with
these Cre transgenic mice to generate Eva1aflox/flox; Nestin-Cre
mice. All mice used in the study were bred and maintained at the
Experimental Animal Center, Peking University Health Sciences
Center (Beijing, China). The animal experiment protocol was
approved by the Biomedical Research Ethics Committee of Peking
University and strictly adhered to the American Physiological Soci-
ety’s Guiding Principles in the Care and Use of Vertebrate Animals in
Research and Training.
Determination of the Genotype of Eva1aMutant
Embryos
To genotype embryos, early-stage embryos’ tails were cut and then
the genome was genotyped by PCR. The primers used in this study
are listed in Table S1.
Protein Extraction and Western Blotting
Total proteins frommouse tissues or cells were extracted using lysis
buffer (50 mM Tris [pH 7.4], 150 mM NaCl, 1% Triton X-100, 1%
sodium deoxycholate, 0.1% SDS, and with freshly added protein-
ase inhibitor cocktail and phosphatase inhibitors). Protein concen-
trations were determined by the BCA protein assay reagent (Pierce,
NCI3227CH). Equal amounts of proteins were separated by SDS-
PAGE electrophoresis and transferred to nitrocellulose mem-
branes. After blocking with 5% nonfat milk, the membranes
were incubated with primary antibodies, washed, and then incu-
bated with the secondary antibodies. The membranes were then
washed and scanned using an Odyssey Infrared Imaging System
(LI-COR Biosciences). Scanned bands were quantified using the
ImageJ software. The results were representative of at least three
experiments.
Immunofluorescence
Brain frozen sections from both Eva1a/ and Eva1a+/+ mice at
E12.5 and E16.5 were fixed with 4% formaldehyde, washed with
PBS, and blocked with PBS with 5% BSA and 0.25% Triton X-100
at room temperature for 1 hr. The sections were incubated with
the indicated primary antibody at 4C overnight, washed with
PBS three times, and incubated with fluorescein isothiocyanates
(FITC) or rhodamine-labeled secondary antibodies at 37C for
1 hr. Nuclei were stained with Hoechst 33342 for 5 min. Finally,
immunofluorescence was detected under a confocal fluorescence408 Stem Cell Reports j Vol. 6 j 396–410 j March 8, 2016 j ª2016 The Authomicroscope (LSM 510 Meta plus Axiovert zoom, Carl Zeiss) with
a 633/1.40 NA oil immersion objective lens (PlanApochromat;
Carl Zeiss) and a camera (AxioCam HRm, Carl Zeiss). Images
were processed and viewed using the LSM Image Browser software.
RT-PCR
Total RNA was extracted from mice tissues or cells using the Trizol
reagent (Invitrogen, 15596-026). RT-PCR was performed using
0.1 mg of cDNA with a 23 Taq mastermix (CWBIO, cw0682) and
10 pmol/ml of primers. Reactions were run on a Bio-Rad MyCycler
Thermal Cycler, and PCR products were analyzed by agarose gel
electrophoresis. Theprimersused in this studyare listed inTable S2.
BrdU Incorporation Assay
Cell proliferation was detected using bromodeoxyuridine (BrdU)
(Sigma-Aldrich, B5002). Briefly, BrdU was dissolved in 0.9% sterile
NaCl and filtered through a 0.22-mm filter. BrdU was then applied
to pregnant female mice by intraperitoneal injection (50 mg/kg)
4 hr before euthanasia. The embryos were removed, and the tail
from each embryo was collected for genotyping. The brain of
each embryo was immediately fixed in 4% paraformaldehyde.
Two days later, the fixed brains were transferred to a solution of
30% sucrose in PBS for cryopreservation. Cryostat sections of the
brains were cut in the coronal plane at a thickness of 10 mm and
collected on Superfrost Plus slides (VWR). Brain sectionswere incu-
bated in 2 N HCl at 37C for 30 min and rinsed in borate buffer
(pH 8.5) for 15 min. The sections were then incubated with an
anti-BrdU antibody (Bioworld, MB6004) at 4C overnight after
DNA denaturation.
For double labeling of BrdU and NESTIN or b-TUBULIN III, sec-
tions were incubated with an anti-BrdU antibody and the indi-
cated antibodies for each cell marker at 4C overnight after DNA
denaturation. Immunofluorescence analysis was performed as
described above.
Cell Culture and Treatments
Primary NSCs generated from E12.5 embryos from Eva1a+/+ and
Eva1a/ mice were cultured in Dulbecco’s modified Eagle’s me-
dium (DMEM/F12, GIBCO, 42400-028) supplemented with 2%
B27, 20 ng/ml basic fibroblast growth factor (bFGF) and epidermal
growth factor, 100 U/ml penicillin, 100 mg/ml streptomycin, and
2 mM glutamine. Cells were resuspended in DMEM/F12 medium,
and then plated onto uncoated tissue culture dishes at 3.5 3 104
cells/cm2 and incubated at 37C in 5% CO2.
To induce cell differentiation, neurospheres from cultures of less
than ten passages were plated at a density of 105 cells/cm2 on cov-
erslips coated with 15 mg/ml poly-ornithine (Sigma-Aldrich,
P4957), supplemented withN2 (Gibco BRL, 17502048) containing
0.5 mM all-trans retinoic acid (Wako, R117), 0.5% fetal bovine
serum without bFGF, and incubated for 6 days. The medium was
replaced every 2 days.
To study thecorrelationbetweenenergyavailability andneuronal
differentiation, 10 mM methylpyruvate was added to the culture
medium for 6 days. The culture medium was supplemented
with 1.5 mg/ml sodium bicarbonate to maintain the pH balance
in the presence of MP, and replaced every 24 hr. Cells were then
fixed for immunofluorescence or lysed for western blotting.rs
To detect LC3B distribution, NSCs from Eva1a+/+ and Eva1a/ at
E12.5 were cultured under proliferative conditions and plated on
glass coverslips coated with poly-ornithine for 24 hr. NSCs were
subjected to immunofluorescence against LC3B and viewed under
a confocal fluorescence microscopy.
The recombinant viral plasmid Ad5-Eva1awas prepared by Sino-
GenoMax. NSCs were infected by incubation with Ad5-Eva1a for
12–16hr, and thenfixed for immunofluorescence or lysed for west-
ern blotting.
Neurosphere Formation Assay
We collected NSCs on culture day 3 and dissociated them using a
NeuroCult cell dissociation kit (Stem Cell Technologies, 05707),
and cultured them in 96-well non-coated plates with 500 or
1,000 cells per well. Analyses were performed after 5–7 days in cul-
ture. Images of neurospheres (NSs) in 8wells per experimental con-
dition were acquired and analyzed using ImageJ software to quan-
tify both the number of NSs and the diameter of individual NSs. All
data presented are the results of three to four separate experiments.
Measurement of Neurite Length
To visualize neuronal morphology, cells were stained with anti-
b-TUBULIN III antibodies, followed by incubation with Texas
Red secondary antibody (Molecular Probes, T2767) or with Alexa
488 antibody (Molecular Probes, A1101). Cell nuclei were counter-
stained with Hoechst 33342. Neurites were classified as primary
(predominant processes emerging directly from the cell body) or
secondary (processes emerging from a primary neurite). Images
of the cells were taken at 403 or 633 magnification using a
confocal laser scanning microscope (Olympus). Thirty visual fields
were chosen randomly and 30 individual images were taken from
each group. Neurite length was measured using the NIH ImageJ
software.
Apoptosis Detection
Apoptosis in tissue was detected using an In Situ Cell Death Detec-
tion Kit (Roche, 1168479591) by TUNEL assays. Brain frozen sec-
tions from both Eva1a/ and Eva1a+/+ mice at E12.5 were treated
and stained according to the manufacturer’s directions. The nuclei
were stained withHoechst 33342 and imaged under a confocalmi-
croscope. The percentage of TUNEL-positive cells was calculated as
the mean of ten different fields from each specimen.
Cell apoptosis was detected by flow cytometry. Primary NSCs
generated from Eva1a/ and Eva1a+/+ mice at E12.5 were cultured
in Dulbecco’s modified Eagle’s medium for 3 days, trypsinized, and
resuspended in 100 ml of binding buffer containing 5 ml of FITC-
conjugated Annexin V, and incubated at room temperature in
the dark for 30 min. The cells were stained with propidium iodide
and analyzed on a FACS Calibur flow cytometer (Becton
Dickinson).
Statistical Analysis
The statistical significance of the mean differences observed be-
tween samples was determined by the Student two-tailed t test us-
ing SPSS 18.0. One-way ANOVA with Tukey’s post hoc test was
used to compare means of more than three samples using SPSS
18.0. Data are shown as means ± SD of the results of at least threeStemindependent experiments. Values of p < 0.05 were considered
significant.SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental
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